-
Athira Pharma Announces COO Appointment
americanpharmaceuticalreview
July 17, 2019
Athira Pharma announced the appointment of Mark Litton, PhD, MBA as Chief Operating Officer.
-
Compugen Announces Board of Directors Appointment
americanpharmaceuticalreview
July 03, 2019
Compugen announced the appointment of Eran Perry to its board of directors, effective July 1, 2019. In addition, the Company announced that Yair Aharonowitz, Ph.D. and Arie Ovadia, Ph.D. will retire from its board of directors and will not be brought for
-
Many Buprenorphine Prescribers Not Offering New Appointments
drugs
June 04, 2019
Many buprenorphine prescribers not offering new appointments.
-
Lannett Announces Board of Directors Appointment
americanpharmaceuticalreview
May 24, 2019
Lannett announced the appointment of Melissa V. Rewolinski, PhD, to its board of directors, effective July 1, 2019. Following the appointment of Dr. Rewolinski, the board will comprise eight directors.
-
Aptorum Group Limited announces appointment of Head of R&D and COO
biospectrumasia
April 03, 2019
Aptorum Group Limited has announced the appointment of Dr. Thomas Wai-yip Lee as Head of Research and Development and Dr. Angel Siu-yan Ng as Chief Operating Officer of Aptorum, effective on April 1, 2019.
-
Lupin appoints Christine Mundkur as Independent Director
expressbpd
April 03, 2019
She most recently served as Chief Executive Officer and non-voting Chairman of the Board of Directors for Impopharma Inc
-
Glenmark appoints Alessandro Riva as CEO of its new innovation company in US
expressbpd
March 07, 2019
The appointment is effective April 2, 2019
-
Lonza Endotoxin Expert Appointed Chair of ASMFC Horseshoe Crab Panel
contractpharma
November 15, 2018
Burgenson elected to position in recognition of more than 35 years of experience in the biomedical use of horseshoe crabs
-
OncoSec Appoints Chief Clinical Development Officer
expressbpd
October 30, 2018
The award was given in recognition of the exemplary contributions to the profession and improvement of society in line with the mission of FAPA in Asia
-
Achillion appoints new CMO
biospectrumasia
August 22, 2018
Achillion also expanded its clinical development group with the recent appointments of Laura Barrow, Pharm.D. as VP, Clinical Operations and Head of Project Management, and Marc Uknis, M.D. as VP of Clinical Development, Head of Nephrology Therapeutics.